Yahoo Web Search

Search results

1. • Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?

     Medscape· 8 hours ago

     In February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a new regimen for first-line metastatic pancreatic adenocarcinoma called ...

2. • 

     A pest of our own making: revealing the true origins of the not-so-German cockroach - EconoTimes

     EconoTimes· 5 hours ago

     German cockroaches thrive in buildings all over the world. Theyre one of the most common cockroach...

3. • US FDA Approves Amgen Drug for Small Cell Lung Cancer

     US News & World Report· 5 days ago

     The drug, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific antibodies designed to attach to a cancer cell and an immune cell, bringing them together so that the body's ...

4. • DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...

     WTRF Wheeling· 1 hour ago

     DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening ...

5. • 

     Immunotherapy may boost survival after lung cancer surgery

     UPI· 5 days ago

     Immunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...

6. • 

     Most cancer treatments are useless for patients with advanced tumors near end of life

     UPI· 4 days ago

     Chemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival...

7. • 

     Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?

     Investor's Business Daily· 7 days ago

     Progression-free survival is how long patients live before their cancer worsens. The company added...

8. • Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating...

     Morningstar· 1 day ago

     (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the strong antiviral activity...the NV-387 treated group survived ...

9. • 

     Square: Restaurant Worker Pay Jumps 66% in 7 Years

     PYMNTS.com· 7 days ago

     Labor costs continue to weigh on restaurants, according to a new report by Square. The point-of-sale payments company’s Quarterly Restaurant Report,...

10. • Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting

      WFRV 5 Green Bay· 8 hours ago

      Hansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of ...